Cemdisiran
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Cemdisiran, covering 2023-12-08 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently [Phase 3]